상세 보기
Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies: 5-year follow-up of a pivotal Phase II study
- Budde, Elizabeth;
- Sehn, Laurie;
- Matasar, Matthew;
- Schuster, Stephen;
- Assouline, Sarit;
- ... Kim, Won-Seog;
- 외 14명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Fixed treatment duration mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies: 5-year follow-up of a pivotal Phase II study
- 저자
- Budde, Elizabeth; Sehn, Laurie; Matasar, Matthew; Schuster, Stephen; Assouline, Sarit; Kuruvilla, John; Kim, Won-Seog; Cheah, Chan; Shadman, Mazyar; Dietrich, Sascha; Ku, Matthew; El-Sharkawi, Dima; Gutierrez, Norma; Wei, Michael C.; Yin, Shen; Sit, Jason; Tracy, Samuel; Sabalvaro, Fidelis; Peneul, Elicia; Bartlett, Nancy
- 발행일
- 2025-11-03
- 유형
- Meeting Abstract
- 저널명
- Blood
- 권
- 146
- 페이지
- 5352 ~ 5353